Exodus Point Capital Management, LP Vanda Pharmaceuticals Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 21,542 shares of VNDA stock, worth $117,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,542
Previous 79,160
72.79%
Holding current value
$117,619
Previous $363,000
71.9%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VNDA
# of Institutions
151Shares Held
45.4MCall Options Held
20KPut Options Held
999K-
Black Rock Inc. New York, NY8.14MShares$44.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$19.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$18.8 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$17 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$14.1 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $309M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...